EUVIMEDEUVIMED entdecken
Crossref

Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis

Sam Freeman, John Slater

Tissue Engineering Part C: Methods · 2026

DOI: 10.1177/19373384251404201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue Engineering Part C: Methods, 2026. Verfasst von Sam Freeman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Brain Neoplasms, Tissue Engineering, Brain. Die Arbeit nennt 44 Literaturangaben. Gefördert von: national institutes of health, national institute of general medical sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain metastases of triple-negative breast cancer (TNBC) rapidly progress, causing severe neurological decline with a median survival of less than 6 months. This tragic disease is often difficult to identify with sufficient time for treatment and is exacerbated by a lack of effective pharmacological intervention. Replicating the biochemical and mechanical properties of the premetastatic niche in vitro is a critical step in expediting the development of new therapeutics. However, a high-fidelity and reproducible model system is needed. To quantify the influence of a brain-mimetic microenvironment on brain metastatic TNBC, we encapsulated and cultured the TNBC cell line, MDA-MB-231 (P231), and its braintropic subline, MDA-MB-231-BrM2a-831 (BrM2a), in three premetastatic niches: a highly cell-adhesive and highly cell-degradable permissive niche, a highly adhesive but less degradable niche, and a nonadhesive but highly degradable niche. To mimic brain extracellular matrix, we functionalized the adhesive formulations with a brain-mimetic peptide cocktail and compared the cell responses to a “generic” RGDS-functionalization. This suite of conditions allowed us to investigate the influences of integrin-mediated adhesion, cell-mediated degradation, and cell type on the fate of P231s and BrM2as. Our data demonstrate that brain-mimetic adhesion has little to no impact on P231 phenotype, but the BrM2as display reduced viable cell density, reduced proliferation, and a higher proportion of both spherical clusters and spherical individual cells compared with the “generic” RGDS-functionalized niches. This suggests that brain-mimetic adhesion signaling encourages a rounded, less invasive phenotype in BrM2as. Modeling pathological processes usingadvanced, biomimetic in vitro models that better replicate in vivo cell phenotype have the potentialtoenhanceimprove the outcome of preclinical therapeutic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsBrain NeoplasmsTissue EngineeringBrainModels, BiologicalBiomimetic MaterialsHumansMDA-MB-231 CellsFemaleCell AdhesionCell Line, TumorTumor MicroenvironmentExtracellular Matrix

Stichwörter der Autor:innen

3D cell culturebiomimeticsextracellular matrixhydrogelstumor models

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Delaware, Newark, Delaware, USA.

Förderung

  • national institutes of health
  • national institute of general medical sciences

Zitieren

APA

Freeman, S., & Slater, J. (2026). Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis. Tissue Engineering Part C: Methods. https://doi.org/10.1177/19373384251404201

Vancouver

Freeman S, Slater J. Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis. Tissue Engineering Part C: Methods. 2026. doi:10.1177/19373384251404201

BibTeX
@article{Freeman2026,
  author = {Freeman, Sam and Slater, John},
  title = {Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis},
  journal = {Tissue Engineering Part C: Methods},
  year = {2026},
  doi = {10.1177/19373384251404201}
}
Kostenlos starten →